Introduction: Premature ovarian insufficiency (POI) is not an uncommon phenomenon among patients who consulted during the assisted reproduction campaign. Objective: The aim of our study was to investigate the frequency and factors associated with premature ovarian failure (POI) in a cohort of women during the campaign for assisted reproduction at the University Teaching Hospital of Bogodogo (UTH-B) from December 15, 2022 to June 15, 2023. Methodology: We conducted a retrospective descriptive and analytical cross-sectional study from 2022 to 2023. The study population consisted of women with POI. Data were collected using a questionnaire containing the variables. We calculated frequency, crude odds ratios (crude OR) and adjusted odds ratios (adjusted OR) at a 95% confidence interval, and variables with a p-value < 0.05 were considered statistically significant.Results: The prevalence of premature ovarian failure was 4.42%. Factors independently associated with premature ovarian failure were irregularity of menstrual cycle [OR = 10.35, CI95% = (4.04-26.50), p = 0.001]; history of twins [OR = 3.55, CI95% = (1.63-7.69), p = 0.001]; absence of history of gestation [OR = 1.47, CI95% = (1.02-2.15), p = 0.047]. Conclusion: The study showed that POI remains a major challenge in reproductive health, due to its relatively high frequency. Action is needed to raise awareness of the signs, so that the population can be consulted at an early stage.
References
[1]
ReGe, G., FoidaRt, J.M. and Nisolle, M. (2012) Prematured Ovarian Insufficiency. Revue Médicale de Liège, 7, 413-419.
[2]
Torrealday, S., Kodaman, P. and Pal, L. (2017) Premature Ovarian Insufficiency—An Update on Recent Advances in Understanding and Management. F1000Research, 6, Article 2069. https://doi.org/10.12688/f1000research.11948.1
[3]
Torrealday, S. and Pal, L. (2015) Premature Menopause. EndocrinologyandMetabolismClinicsofNorthAmerica, 44, 543-557. https://doi.org/10.1016/j.ecl.2015.05.004
[4]
Moustaki, M., Kontogeorgi, A., Tsangkalova, G., Tzoupis, H., Makrigiannakis, A., Vryonidou, A., etal. (2023) Biological Therapies for Premature Ovarian Insufficiency: What Is the Evidence? FrontiersinReproductiveHealth, 5, Article 1194575. https://doi.org/10.3389/frph.2023.1194575
[5]
Lagergren, K., Hammar, M., Nedstrand, E., Bladh, M. and Sydsjö, G. (2018) The Prevalence of Primary Ovarian Insufficiency in Sweden; a National Register Study. BMCWomen’sHealth, 18, Article No. 175. https://doi.org/10.1186/s12905-018-0665-2
[6]
Leone, T., Brown, L. and Gemmill, A. (2023) Secular Trends in Premature and Early Menopause in Low-Income and Middle-Income Countries. BMJGlobalHealth, 8, e012312. https://doi.org/10.1136/bmjgh-2023-012312
[7]
Coulibaly, I. (2023) MPA Management of Premature Ovarian Failure in a Private Health Facility in the City of Ouagadougou in Burkina Faso from January 2021 to December 2022. Gynecology and Obstetrics, Université Joseph Ki Zerbo.
[8]
Ministry of Health Burkina Faso (2018) Statistical Yearbook 2016 and 2017. 303.
[9]
Kafando, J.G. (2020) Artificial Inseminations for Infertile Couples at the St Jérémie Clinic: Indications and Results from January 1, 2010 to December 31, 2019. Thesis Diploma of Specialized Studies in Gynecology Obstetrics, Joseph Ki Zerbo University —Training and Research Unit in Health Sciences.
[10]
Sakande, J., Sandjon, L., Ouedraogo, C., Konyaole, E., Kabre, E. and Sawadogo, M. (2012) Profil hormonal féminin et pronostic de la réponse à la stimulation ovarienne au cours de l’Assistance Médicale à la Procréation: Expérience du Burkina Faso. InternationalJournalofBiologicalandChemicalSciences, 6, 950-958. https://doi.org/10.4314/ijbcs.v6i3.4
[11]
Mukandila, A.M., Sangula, M.K., Katumba, M.M., Kitengie, N., Tshiyamba, J.T., Kasongo, K., etal. (2020) Prevalence, Some Inherent Factors and Experience of Menopause in a Semi-Urban Environment (Case of the Town of Mwene-Ditu), Eastern Kasaia in the Democratic Republic of Congo. Revue Médicale des Grands Lacs, 11, 29.
[12]
Mishra, G.D., Chung, H., Cano, A., Chedraui, P., Goulis, D.G., Lopes, P., etal. (2019) EMAS Position Statement: Predictors of Premature and Early Natural Menopause. Maturitas, 123, 82-88. https://doi.org/10.1016/j.maturitas.2019.03.008
[13]
Yasui, T., Hayashi, K., Mizunuma, H., Kubota, T., Aso, T., Matsumura, Y., etal. (2012) Factors Associated with Premature Ovarian Failure, Early Menopause and Earlier Onset of Menopause in Japanese Women. Maturitas, 72, 249-255. https://doi.org/10.1016/j.maturitas.2012.04.002
[14]
Mishra, G.D., Pandeya, N., Dobson, A.J., Chung, H., Anderson, D., Kuh, D., etal. (2017) Early Menarche, Nulliparity and the Risk for Premature and Early Natural Menopause. HumanReproduction, 32, 679-686. https://doi.org/10.1093/humrep/dew350
[15]
Yeo, J.H. and Kim, M.T. (2022) Association of Weight, Smoking, and Alcohol Consumption with Age at Natural Menopause. JournalofWomen&Aging, 35, 343-353. https://doi.org/10.1080/08952841.2022.2050157
[16]
Jambarsang, S., Khodayarian, M., Sefidkar, R. and Yoshany, N. (2023) Prevalence of Premature Ovarian Insufficiency (POI) and Its Relationship with Female Reproductive Factors in Iranian Women: A Cross-Sectional Study from the Persian (shahedieh) Cohort Data. BMCWomen’sHealth, 23, Article No. 467. https://doi.org/10.1186/s12905-023-02620-9
[17]
Rostami Dovom, M., Bidhendi-Yarandi, R., Mohammad, K., Farahmand, M., Azizi, F. and Ramezani Tehrani, F. (2021) Prevalence of Premature Ovarian Insufficiency and Its Determinants in Iranian Populations: Tehran Lipid and Glucose Study. BMCWomen’sHealth, 21, Article No. 79. https://doi.org/10.1186/s12905-021-01228-1
[18]
Lim, Y., Jeong, K., Lee, S.R., Chung, H.W. and Lee, W. (2019) Association between Premature Ovarian Insufficiency, Early Menopause, Socioeconomic Status in a Nationally Representative Sample from Korea. Maturitas, 121, 22-27. https://doi.org/10.1016/j.maturitas.2018.12.004
[19]
Bustami, M., Matalka, K.Z., Elyyan, Y., Hussein, N., Hussein, N., Abu Safieh, N., etal. (2021) Age of Natural Menopause among Jordanian Women and Factors Related to Premature and Early Menopause. RiskManagementandHealthcarePolicy, 14, 199-207. https://doi.org/10.2147/rmhp.s289851
[20]
Sato, T., Kusuhara, A., Kasahara, Y., Haino, T., Kishi, H. and Okamoto, A. (2021) Follicular Development during Hormone Replacement Therapy in Patients with Premature Ovarian Insufficiency. ReproductiveMedicineandBiology, 20, 234-240. https://doi.org/10.1002/rmb2.12375
[21]
Zhu, D.S., Chung, H.-F., Pandeya, N., Dobson, A.J., Cade, J.E., Greenwood, D.C., etal. (2018) Relationships between Intensity, Duration, Cumulative Dose, and Timing of Smoking with Age at Menopause: A Pooled Analysis of Individual Data from 17 Observational Studies. PLOSMedicine, 15, e1002704. https://doi.org/10.1371/journal.pmed.1002704
[22]
Gupta, A., Tiwari, P. and Khare, C. (2019) Premature Ovarian Insufficiency: A Review. https://www.emjreviews.com/reproductive-health/article/premature-ovarian-insufficiency-a-review/
[23]
Bompoula, M.S., Valsamakis, G., Neofytou, S., Messaropoulos, P., Salakos, N., Mastorakos, G., et al. (2020) Demographic, Clinical and Hormonal Characteristics of Patients with Premature Ovarian Insufficiency and Those of Early Menopause: Data from Two Tertiary Premature Ovarian Insufficiency Centers in Greece. GynecologicalEndocrinology, 36, 693-697. https://doi.org/10.1080/09513590.2020.1739266
[24]
Sullivan, S.D., Sarrel, P.M. and Nelson, L.M. (2016) Hormone Replacement Therapy in Young Women with Primary Ovarian Insufficiency and Early Menopause. FertilityandSterility, 106, 1588-1599. https://doi.org/10.1016/j.fertnstert.2016.09.046
[25]
Bertone-Johnson, E.R., Manson, J.E., Purdue-Smithe, A.C., Steiner, A.Z., Eliassen, A.H., Hankinson, S.E., etal. (2018) Anti-Müllerian Hormone Levels and Incidence of Early Natural Menopause in a Prospective Study. HumanReproduction, 33, 1175-1182. https://doi.org/10.1093/humrep/dey077
[26]
Whitcomb, B.W., Purdue-Smithe, A., Hankinson, S.E., Manson, J.E., Rosner, B.A. and Bertone-Johnson, E.R. (2018) Menstrual Cycle Characteristics in Adolescence and Early Adulthood Are Associated with Risk of Early Natural Menopause. TheJournalofClinicalEndocrinology&Metabolism, 103, 3909-3918. https://doi.org/10.1210/jc.2018-01110
[27]
Lambrinoudaki, I., Paschou, S.A., Lumsden, M.A., Faubion, S., Makrakis, E., Kalantaridou, S., etal. (2021) Premature Ovarian Insufficiency: A Toolkit for the Primary Care Physician. Maturitas, 147, 53-63. https://doi.org/10.1016/j.maturitas.2020.11.004
